v3.26.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Dec. 20, 2024
USD ($)
Jul. 10, 2024
USD ($)
option
Jun. 30, 2022
USD ($)
Lessee, Lease, Description [Line Items]          
Future minimum lease payments under operating lease liabilities $ 200        
Number of extension options | option       2  
Accrued rent receivable 7,968 $ 7,664      
Non Cancelable Purchase Commitments with Contract Research Organizations | Contract Terminations | Restructuring Plan          
Lessee, Lease, Description [Line Items]          
Restructuring costs   200      
Secured Mortgage Loan | Loans Payable          
Lessee, Lease, Description [Line Items]          
Initial principal amount         $ 52,100
2024 Loan | Loans Payable          
Lessee, Lease, Description [Line Items]          
Initial principal amount 85,600 85,600 $ 85,600    
Unamortized debt issuance cost $ 601 $ 794      
Debt instrument term (in years) 2 years        
Debt instrument, extension option, term (in years) 1 year        
Debt instrument, extension fee, percentage 0.35%        
Bears interest, percentage 6.35%        
Complex Therapeutics LLC          
Lessee, Lease, Description [Line Items]          
Term of contract (in years)       15 years  
Renewal term (in years)       5 years  
Base rent, per month       $ 600  
Base rent, per annually       $ 7,500  
Rents increase in percentage       3.00%  
Minimum          
Lessee, Lease, Description [Line Items]          
Original lease terms 2 years        
Maximum          
Lessee, Lease, Description [Line Items]          
Original lease terms 5 years        
Maximum | Secured Mortgage Loan | Loans Payable          
Lessee, Lease, Description [Line Items]          
Additional future principal (up to)         $ 32,900